NCT03920839 2020-04-24
INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105)
Incyte Corporation
Phase 1 Withdrawn
Incyte Corporation
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
University College, London